Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus

Frontiers in Neurology

Volumn 6, Issue , 2015, Pages

  Hazeldine, Jon ^a,b   Lord, Janet M ^a,b   Belli, Antonio ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

immune suppression; immune system; infection; traumatic brain injury

Indexed keywords

EID: 84995881481     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00235     Document Type: Review

References (170)

1. Menon DK Schwab K Wright DW Maas AI Demographics and Clinical Assessment Working Group of the International and Interagency Initiative toward Common Data Elements for Research on Traumatic Brain Injury and Psychological Health. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil (2010) 91:1637–40.10.1016/j.apmr.2010.05.01721044706
2. Health and Social Care Information Centre. Hospital Episode Statistics, Admitted Patient Care, England 2012-13: Diagnosis (2015). Available from: http://www.hscic.gov.uk/catalogue/PUB16719
3. Faul M Xu L Wald MM Coronado VG. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control (2010).
4. Schwarzbold M Diaz A Martins ET Rufino A Amante LN Thais ME et al. Psychiatric disorders and traumatic brain injury. Neuropsychiatr Dis Treat (2008) 4:797–816.19043523
5. Whelan-Goodinson R Ponsford J Johnston L Grant F. Psychiatric disorders following traumatic brain injury: their nature and frequency. J Head Trauma Rehabil (2009) 24:324–32.10.1097/HTR.0b013e3181a712aa19858966
6. Gustavsson A Svensson M Jacobi F Allgulander C Alonso J Beghi E et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 21:718–79.10.1016/j.euroneuro.2011.08.00821924589
7. Langlois JA Sattin RW. Traumatic brain injury in the United States: research and programs of the centers for disease control and prevention (CDC). J Head Trauma Rehabil (2005) 20:187–8.10.1097/00001199-200505000-00001
8. Center TBI. 10 Facts About TBI (2015). Available from: www.center-tbi.eu/patients/facts
9. Cazzadori A Di Perri G Vento S Bonora S Fendt D Rossi M et al. Aetiology of pneumonia following isolated closed head injury. Respir Med (1997) 91:193–9.10.1016/S0954-6111(97)90038-X9156141
10. Bronchard R Albaladejo P Brezac G Geffroy A Seince PF Morris W et al. Early onset pneumonia: risk factors and consequences in head trauma patients. Anesthesiology (2004) 100:234–9.10.1097/00000542-200402000-0000914739794
11. Zygun DA Zuege DJ Boiteau PJ Laupland KB Henderson EA Kortbeek JB et al. Ventilator-associated pneumonia in severe traumatic brain injury. Neurocrit Care (2006) 5:108–14.10.1385/NCC:5:2:10817099256
12. Kourbeti IS Papadakis JA Neophytou C Filippou M Ioannou A Karabetsos DA et al. Infections in patients with traumatic brain injury who undergo neurosurgery. Br J Neurosurg (2011) 25:9–15.10.3109/02688697.2010.50041120649406
13. Kourbeti IS Vakis AF Papadakis JA Karabetsos DA Bertsias G Filippou M et al. Infections in traumatic brain injury patients. Clin Microbiol Infect (2012) 18:359–64.10.1111/j.1469-0691.2011.03625.x21851488
14. Schirmer-Mikalsen K Moen KG Skandsen T Vik A Klepstad P. Intensive care and traumatic brain injury after the introduction of a treatment protocol: a prospective study. Acta Anaesthesiol Scand (2013) 57:46–55.10.1111/j.1399-6576.2012.02785.x23095138
15. Rincón-Ferrari MD Flores-Cordero JM Leal-Noval SR Murillo-Cabezas F Cayuelas A Muñoz-Sánchez MA et al. Impact of ventilator-associated pneumonia in patients with severe head injury. J Trauma (2004) 57:1234–40.10.1097/01.TA.0000119200.70853.2315625455
16. Rondina C Videtta W Petroni G Lujan S Schoon P Mori LB et al. Mortality and morbidity from moderate to severe traumatic brain injury in Argentina. J Head Trauma Rehabil (2005) 20:368–76.10.1097/00001199-200507000-0000816030443
17. Glance LG Stone PW Mukamel DB Dick AW. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg (2011) 146:794–801.10.1001/archsurg.2011.4121422331
18. Selassie AW Fakhry SM Ford DW. Population-based study of the risk of in-hospital death after traumatic brain injury: the role of sepsis. J Trauma (2011) 71:1226–34.10.1097/TA.0b013e318226ecfc22071924
19. Cardozo Junior LC Silva RR. Sepsis in intensive care unit patients with traumatic brain injury: factors associated with higher mortality. Rev Bras Ter Intensiva (2014) 26:148–54.10.5935/0103-507X.2014002225028949
20. Vitaz TW Jenks J Raque GH Shields CB. Outcome following moderate traumatic brain injury. Surg Neurol (2003) 60:285–91.10.1016/S0090-3019(03)00378-114505837
21. Piek J Chesnut RM Marshall LF van Berkum-Clark M Klauber MR Blunt BA et al. Extracranial complications of severe head injury. J Neurosurg (1992) 77:901–7.10.3171/jns.1992.77.6.09011432133
22. Venturi L Miranda M Selmi V Vitali L Tani A Margheri M et al. Systemic sepsis exacerbates mild post-traumatic brain injury in the rat. J Neurotrauma (2009) 26:1547–56.10.1089/neu.2008-072319257801
23. Meisel C Schwab JM Prass K Meisel A Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci (2005) 6:775–86.10.1038/nrn176516163382
24. Hoyt DB Ozkan AN Hansbrough JF Marshall L vanBerkum-Clark M. Head injury: an immunologic deficit in T-cell activation. J Trauma (1990) 30:759–66.10.1097/00005373-199007000-000011974309
25. Quattrocchi KB Frank EH Miller CH MacDermott JP Hein L Frey L et al. Suppression of cellular immune activity following severe head injury. J Neurotrauma (1990) 7:77–87.10.1089/neu.1990.7.772376866
26. Miller CH Quattrocchi KB Frank EH Issel BW Wagner FC Jr. Humoral and cellular immunity following severe head injury: review and current investigations. Neurol Res (1991) 13:117–24.1682838
27. Quattrocchi KB Frank EH Miller CH Amin A Issel BW Wagner FC Jr. Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury. J Neurosurg (1991) 75:766–73.10.3171/jns.1991.75.5.0766
28. Quattrocchi KB Frank EH Miller CH Dull ST Howard RR Wagner FC Jr. Severe head injury: effect upon cellular immune function. Neurol Res (1991) 13:13–20.
29. Quattrocchi KB Miller CH Wagner FC Jr DeNardo SJ DeNardo GL Ovodov K et al. Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors. J Neurosurg (1992) 77:694–9.10.3171/jns.1992.77.5.06941403109
30. Shimonkevitz R Bar-Or D Harris L Dole K McLaughlin L Yukl R. Transient monocyte release of interleukin-10 in response to traumatic brain injury. Shock (1999) 12:10–6.10.1097/00024382-199907000-0000210468046
31. Mrakovcic-Sutic I Tokmadzic VS Laskarin G Mahmutefendic H Lucin P Zupan Z et al. Early changes in frequency of peripheral blood lymphocyte subpopulations in severe traumatic brain-injured patients. Scand J Immunol (2010) 72:57–65.10.1111/j.1365-3083.2010.02407.x20591077
32. Sotosek Tokmadzic V Laskarin G Mahmutefendic H Lucin P Mrakovcic-Sutic I Zupan Z et al. Expression of cytolytic protein-perforin in peripheral blood lymphocytes in severe traumatic brain injured patients. Injury (2012) 43:624–31.10.1016/j.injury.2010.05.00920537642
33. Subramanian A Agrawal D Pandey RM Nimiya M Albert V. The leukocyte count, immature granulocyte count and immediate outcome in head injury patients. In: Agrawal A, editor. Brain Injury – Pathogenesis, Monitoring, Recovery and Management (2012).10.5772/27020
34. Junger WG Rhind SG Rizoli SB Cuschieri J Baker AJ Shek PN et al. Prehospital hypertonic saline resuscitation attenuates the activation and promotes apoptosis of neutrophils in patients with severe traumatic brain injury. Shock (2013) 40:366–74.10.1097/SHK.000000000000003824088993
35. Liao Y Liu P Guo F Zhang ZY Zhang Z. Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS One (2013) 8:e68963.10.1371/journal.pone.006896323894384
36. Marks W Gołabek-Dropiewska K Bryl E Dudek R Wieruszewski J Stasiak M et al. Immunomonitoring in patients with early moderate and severe head trauma. Cent Eur J Public Health (2013) 38:494–9.10.5114/ceji.2013.39767
37. Schwulst SJ Trahanas DM Saber R Perlman H. Traumatic brain injury-induced alterations in peripheral immunity. J Trauma Acute Care Surg (2013) 75:780–8.10.1097/TA.0b013e318299616a24158195
38. Kong XD Bai S Chen X Wei HJ Jin WN Li MS et al. Alterations of natural killer cells in traumatic brain injury. Neurosci Bull (2014) 30:903–12.10.1007/s12264-014-1481-925446874
39. Rhind SG Crnko NT Baker AJ Morrison LJ Shek PN Scarpelini S et al. Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. J Neuroinflammation (2010) 7:5.10.1186/1742-2094-7-520082712
40. Wolach B Sazbon L Gavrieli R Broda A Schlesinger M. Early immunological defects in comatose patients after acute brain injury. J Neurosurg (2001) 94:706–11.10.3171/jns.2001.94.5.070611354400
41. Smrcka M Mrlian A Klabusay M. Immune system status in the patients after severe brain injury. Bratisl Lek Listy (2005) 106:144–6.16026152
42. Liles WC Dale DC Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood (1995) 86:3181–8.7579413
43. Yu L Quinn MT Cross AR Dinauer MC. Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc Natl Acad Sci U S A (1998) 95:7993–8.10.1073/pnas.95.14.79939653128
44. Conway Morris A Kefala K Wilkinson TS Dhaliwal K Farrell L Walsh T et al. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med (2009) 180:19–28.10.1164/rccm.200812-1928OC19324972
45. Morris AC Brittan M Wilkinson TS McAuley DF Antonelli J McCulloch C et al. C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood (2011) 117:5178–88.10.1182/blood-2010-08-30466721292772
46. Caron E Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science (1998) 282:1717–21.10.1126/science.282.5394.17179831565
47. Leinhase I Rozanski M Harhausen D Thurman JM Schmidt OI Hossini AM et al. Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J Neuroinflammation (2007) 4:13.10.1186/1742-2094-4-1317474994
48. Neher MD Weckbach S Flierl MA Huber-Lang MS Stahel PF. Molecular mechanisms of inflammation and tissue injury after major trauma – is complement the “bad guy”? J Biomed Sci (2011) 18:90.10.1186/1423-0127-18-90
49. Sewell DL Nacewicz B Liu F Macvilay S Erdei A Lambris JD et al. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J Neuroimmunol (2004) 155:55–63.10.1016/j.jneuroim.2004.06.00315342196
50. Wong KL Yeap WH Tai JJ Ong SM Dang TM Wong SC. The three human monocyte subsets: implications for health and disease. Immunol Res (2012) 53:41–57.10.1007/s12026-012-8297-322430559
51. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol (2007) 81:584–92.10.1189/jlb.080651017135573
52. Hearps AC Martin GE Angelovich TA Cheng WJ Maisa A Landay AL et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell (2012) 11:867–75.10.1111/j.1474-9726.2012.00851.x22708967
53. Yang J Zhang L Yu C Yang XF Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res (2014) 2:1.10.1186/2050-7771-2-124398220
54. Lunemann A Lünemann JD Roberts S Messmer B Barreira da Silva R Raine CS et al. Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. J Immunol (2008) 181:6170–7.10.4049/jimmunol.181.9.6170
55. Aloisi F. Immune function of microglia. Glia (2001) 36:165–79.10.1002/glia.110611596125
56. Hao J Liu R Piao W Zhou Q Vollmer TL Campagnolo DI et al. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 207:1907–21.10.1084/jem.2009274920696699
57. Hao J Campagnolo D Liu R Piao W Shi S Hu B et al. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann Neurol (2011) 69:721–34.10.1002/ana.2233921425186
58. Armant M Delespesse G Sarfati M. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology (1995) 85:331–7.7642225
59. Arruvito L Giulianelli S Flores AC Paladino N Barboza M Lanari C et al. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol (2008) 180:5746–53.10.4049/jimmunol.180.8.574618390760
60. Smyth MJ Ortaldo JR Bere W Yagita H Okumura K Young HA. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol (1990) 145:1159–66.2143209
61. Meert KL Long M Kaplan J Sarnaik AP. Alterations in immune function following head injury in children. Crit Care Med (1995) 23:822–8.10.1097/00003246-199505000-000087736738
62. Marchi N Bazarian JJ Puvenna V Janigro M Ghosh C Zhong J et al. Consequences of repeated blood-barrier disruption in football players. PLoS One (2013) 8:e56805.10.1371/journal.pone.0056805
63. Zhang Z Zoltewicz JS Mondello S Newsom KJ Yang Z Yang B et al. Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PLoS One (2014) 9:e92698.10.1371/journal.pone.009269824667434
64. Nakai A Hayano Y Furuta F Noda M Suzuki K. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J Exp Med (2014) 211:2583–98.10.1084/jem.20141132
65. Clifton GL Ziegler MG Grossman RG. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery (1981) 8:10–4.10.1097/00006123-198101000-000037207763
66. Hamill RW Woolf PD McDonald JV Lee LA Kelly M. Catecholamines predict outcome in traumatic brain injury. Ann Neurol (1987) 21:438–43.10.1002/ana.4102105043592639
67. Katsuura G Arimura A Koves K Gottschall PE. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am J Physiol (1990) 258:E163–71.1967907
68. Dantzer R Konsman JP Bluthé RM Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci (2000) 85:60–5.10.1016/S1566-0702(00)00220-411189027
69. Aspelund A Antila S Proulx ST Karlsen TV Karaman S Detmar M et al. A dural lymphatic vascular system that drains brain interstital fluid and macromolecules. J Exp Med (2015) 212:991–9.10.1084/jem.2014229026077718
70. Louveau A. Structural and functional features of central nervous system lymphatic vessels. Nature (2015) 523:337–41.10.1038/nature1443226030524
71. Cserr HF Harling-Berg CJ Knopf PM. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunoligcal signifcance. Brain Pathol (1992) 2:269–76.10.1111/j.1750-3639.1992.tb00703.x
72. Webster JI Tonelli L Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol (2002) 20:125–63.10.1146/annurev.immunol.20.082401.104914
73. Lee SW Tsou AP Chan H Thomas J Petrie K Eugui EM et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A (1988) 85:1204–8.10.1073/pnas.85.4.12043257575
74. Szabó C Thiemermann C Wu CC Perretti M Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A (1994) 91:271–5.10.1073/pnas.91.1.2717506416
75. Hodge S Hodge G Flower R Han P. Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood. Scand J Immunol (1999) 49:548–53.10.1046/j.1365-3083.1999.00538.x10320649
76. Steer JH Kroeger KM Abraham LJ Joyce DA. Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J Biol Chem (2000) 275:18432–40.10.1074/jbc.M90630419910748079
77. Ray KP Farrow S Daly M Talabot F Searle N. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem J (1997) 328(Pt 2):707–15.10.1042/bj32807079371735
78. Ramírez F Fowell DJ Puklavec M Simmonds S Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol (1996) 156:2406–12.8786298
79. Franchimont D Galon J Gadina M Visconti R Zhou Y Aringer M et al. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol (2000) 164:1768–74.10.4049/jimmunol.164.4.176810657623
80. Kraaij MD van der Kooij SW Reinders ME Koekkoek K Rabelink TJ van Kooten C et al. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol (2011) 49:549–57.10.1016/j.molimm.2011.10.00222047959
81. Duggal NA Upton J Phillips AC Hampson P Lord JM. NK cell immunesenescence is increased by psychological but not physical stress in older adults associated with raised cortisol and reduced perforin expression. Age (Dordr) (2015) 37:9748.10.1007/s11357-015-9748-225663421
82. Jones CJ Morris KJ Jayson MI. Prednisolone inhibits phagocytosis by polymorphonuclear leucocytes via steroid receptor mediated events. Ann Rheum Dis (1983) 42:56–62.10.1136/ard.42.1.566830325
83. Tuckermann JP Kleiman A McPherson KG Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci (2005) 42:71–104.10.1080/1040836059088898315697171
84. Schwiebert LM Schleimer RP Radka SF Ono SJ. Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol (1995) 165:12–9.10.1006/cimm.1995.11817671315
85. Pan J Ju D Wang Q Zhang M Xia D Zhang L et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett (2001) 76:153–61.10.1016/S0165-2478(01)00183-311306142
86. Bellinger DL Lorton D. Autonomic regulation of cellular immune function. Auton Neurosci (2014) 182:15–41.10.1016/j.autneu.2014.01.00624685093
87. Takamoto T Hori Y Koga Y Toshima H Hara A Yokoyama MM. Norepinephrine inhibits human natural killer cell activity in vitro. Int J Neurosci (1991) 58:127–31.10.3109/002074591089871891657810
88. van der Poll T Coyle SM Barbosa K Braxton CC Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest (1996) 97:713–9.10.1172/JCI1184698609227
89. Elenkov IJ Papanicolaou DA Wilder RL Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians (1996) 108:374–81.8902882
90. Trabold B Lunz D Gruber M Froehlich D Graf B. Restoration of neutrophil immunocompetence after cardiopulmonary bypass by beta-adrenergic blockers. Surgery (2010) 147:562–74.10.1016/j.surg.2009.10.02820004448
91. Du Q Min S Chen LY Ma YD Guo XL Wang Z et al. Major stress hormones suppress the response of macrophages through down-regulation of TLR2 and TLR4. J Surg Res (2012) 173:354–61.10.1016/j.jss.2010.10.01621109260
92. Panina-Bordignon P Mazzeo D Lucia PD D’Ambrosio D Lang R Fabbri L et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 100:1513–9.10.1172/JCI1196749294119
93. Woiciechowsky C Asadullah K Nestler D Eberhardt B Platzer C Schöning B et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med (1998) 4:808–13.10.1038/nm0798-8089662372
94. Woiciechowsky C Schöning B Daberkow N Asche K Stoltenburg G Lanksch WR et al. Brain-IL-1beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res (1999) 816:563–71.10.1016/S0006-8993(98)01238-49878881
95. Prass K Meisel C Höflich C Braun J Halle E Wolf T et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 198:725–36.10.1084/jem.2002109812939340
96. Arbabi S Campion EM Hemmila MR Barker M Dimo M Ahrns KS et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma (2007) 62:56–61.10.1097/TA.0b013e31802d972b17215733
97. Cotton BA Snodgrass KB Fleming SB Carpenter RO Kemp CD Arbogast PG et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma (2007) 62:26–33.10.1097/TA.0b013e31802d02d017215730
98. Inaba K Teixeira PG David JS Chan LS Salim A Brown C et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg (2008) 206:432–8.10.1016/j.jamcollsurg.2007.10.00518308212
99. MacKenzie ET McCulloch J Harper AM. Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol (1976) 231:489–94.961902
100. Meyer JS Miyakawa Y Welch KM Itoh Y Ishihara N Chabi E et al. Influence of adrenergic receptor blockade on circulatory and metabolic effects of disordered neurotransmitter function in stroke patients. Stroke (1976) 7:158–67.10.1161/01.STR.7.2.1584907
101. Neil-Dwyer G Walter P Cruickshank JM Doshi B O’Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J (1978) 2:990–2.10.1136/bmj.2.6143.990361155
102. Schroeppel TJ Fischer PE Zarzaur BL Magnotti LJ Clement LP Fabian TC et al. Beta-adrenergic blockade and traumatic brain injury: protective? J Trauma (2010) 69:776–82.10.1097/TA.0b013e3181e981b820938265
103. Borovikova LV Ivanova S Zhang M Yang H Botchkina GI Watkins LR et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 405:458–62.10.1038/35013070
104. Tracey KJ. The inflammatory reflex. Nature (2002) 420:853–9.10.1038/nature0132112490958
105. van Westerloo DJ Giebelen IA Florquin S Daalhuisen J Bruno MJ de Vos AF et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis (2005) 191:2138–48.10.1086/43032315898001
106. Parrish WR Rosas-Ballina M Gallowitsch-Puerta M Ochani M Ochani K Yang LH et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med (2008) 14:567–74.10.2119/2008-00079.Parrish18584048
107. Guarini S Altavilla D Cainazzo MM Giuliani D Bigiani A Marini H et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation (2003) 107:1189–94.10.1161/01.CIR.0000050627.90734.ED12615800
108. Bernik TR Friedman SG Ochani M DiRaimo R Susarla S Czura CJ et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg (2002) 36:1231–6.10.1067/mva.2002.12964312469056
109. Borovikova LV Ivanova S Nardi D Zhang M Yang H Ombrellino M et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci (2000) 85:141–7.10.1016/S1566-0702(00)00233-2
110. Saeed RW Varma S Peng-Nemeroff T Sherry B Balakhaneh D Huston J et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 201:1113–23.10.1084/jem.2004046315809354
111. Wang H Yu M Ochani M Amella CA Tanovic M Susarla S et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2003) 421:384–8.10.1038/nature0133912508119
112. Kawahara E Ikeda S Miyahara Y Kohno S. Role of autonomic nervous dysfunction in electrocardio-graphic abnormalities and cardiac injury in patients with acute subarachnoid hemorrhage. Circ J (2003) 67:753–6.10.1253/circj.67.75312939550
113. Kox M Pompe JC Pickkers P Hoedemaekers CW van Vugt AB van der Hoeven JG. Increased vagal tone accounts for the observed immune paralysis in patients with traumatic brain injury. Neurology (2008) 70:480–5.10.1212/01.wnl.0000279479.69502.3e18250293
114. Hall S Kumaria A Belli A. The role of vagus nerve overactivity in the increased incidence of pneumonia following traumatic brain injury. Br J Neurosurg (2014) 28:181–6.10.3109/02688697.2013.83537324024980
115. Ochoa JB Bernard AC O’Brien WE Griffen MM Maley ME Rockich AK et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg (2001) 233:393–9.10.1097/00000658-200103000-0001411224628
116. Bryk JA Popovic PJ Zenati MS Munera V Pribis JP Ochoa JB. Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma (2010) 68:843–52.10.1097/TA.0b013e3181b026e419996805
117. Pillay J Ramakers BP Kamp VM Loi AL Lam SW Hietbrink F et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol (2010) 88:211–20.10.1189/jlb.120979320400675
118. Pillay J Kamp VM van Hoffen E Visser T Tak T Lammers JW et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest (2012) 122:327–36.10.1172/JCI5799022156198
119. Li H Itagaki K Sandler N Gallo D Galenkamp A Kaczmarek E et al. Mitochondrial damage-associated molecular patterns from fractures suppress pulmonary immune responses via formyl peptide receptors 1 and 2. J Trauma Acute Care Surg (2015) 78:272–9.10.1097/TA.000000000000050925757111
120. Gabrilovich DI Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 9:162–74.10.1038/nri250619197294
121. Filipazzi P Huber V Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother (2012) 61:255–63.10.1007/s00262-011-1161-922120756
122. Zhang K Bai X Li R Xiao Z Chen J Yang F et al. Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma. Int J Mol Med (2012) 30:277–82.10.3892/ijmm.2012.101422664747
123. Jin J Wang X Wang Q Guo X Cao J Zhang X et al. Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice. PLoS One (2013) 8:e74497.10.1371/journal.pone.007449724058577
124. Janols H Bergenfelz C Allaoui R Larsson AM Rydén L Björnsson S et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol (2014) 96:685–93.10.1189/jlb.5HI0214-074R24929004
125. Wesolowski R Markowitz J Carson WE III. Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer. J Immunother Cancer (2013) 1:10.10.1186/2051-1426-1-1024829747
126. Guérin E Orabona M Raquil MA Giraudeau B Bellier R Gibot S et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration*. Crit Care Med (2014) 42:2007–18.10.1097/CCM.000000000000034424942511
127. Wang HC Lin YJ Tsai NW Su BY Kung CT Chen WF et al. Serial plasma deoxyribonucleic acid levels as predictors of outcome in acute traumatic brain injury. J Neurotrauma (2014) 31:1039–45.10.1089/neu.2013.307024467366
128. Walko TD III Bola RA Hong JD Au AK Bell MJ Kochanek PM et al. Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury. Shock (2014) 41:499–503.10.1097/SHK.000000000000016024667615
129. Gyoneva S Ransohoff RM. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol Sci (2015) 36:471–80.10.1016/j.tips.2015.04.00325979813
130. Plog BA Dashnaw ML Hitomi E Peng W Liao Y Lou N et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci (2015) 35:518–26.10.1523/JNEUROSCI.3742-14.201525589747
131. Hazeldine J Hampson P Opoku FA Foster M Lord JM. N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1/2 and P38 MAP kinase signalling pathways. Injury (2015) 46(6):975–84.10.1016/j.injury.2015.03.02825817163
132. Zhang Q Raoof M Chen Y Sumi Y Sursal T Junger W et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 464:104–7.10.1038/nature08780
133. Maile R Jones S Pan Y Zhou H Jaspers I Peden DB et al. Assocation between early airway damage-associated molecular patterns and subsequent bacterial infection in patients with inhalation and burn injury. Am J Physiol Lung Cell Mol Physiol (2015) 308(9):L855–60.10.1152/ajplung.00321.2014
134. Pena OM Hancock DG Lyle NH Linder A Russell JA Xia J et al. An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation. EBioMedicine (2014) 1:64–71.10.1016/j.ebiom.2014.10.00325685830
135. Martinez FO Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 6:13.10.12703/P6-1324669294
136. Fernández-Ruiz I Arnalich F Cubillos-Zapata C Hernández-Jiménez E Moreno-González R Toledano V et al. Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction. PLoS One (2014) 9:e95073.10.1371/journal.pone.009507324797663
137. Wang H Li T Chen S Gu Y Ye S. NETs mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol (2015).10.1002/art.3929626245802
138. Zhang B Angelidou A Alysandratos KD Vasiadi M Francis K Asadi S et al. Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. J Neuroinflammation (2010) 7:80.10.1186/1742-2094-7-80
139. Liesz A Dalpke A Mracsko E Antoine DJ Roth S Zhou W et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci (2015) 35:583–98.10.1523/JNEUROSCI.2439-14.201525589753
140. Wang KY Yu GF Zhang ZY Huang Q Dong XQ. Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury. Clin Chim Acta (2012) 413:1737–41.10.1016/j.cca.2012.07.00222789964
141. Schneider Soares FM Menezes de Souza N Libório Schwarzbold M Paim Diaz A Costa Nunes J Hohl A et al. Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. Neuroimmunomodulation (2012) 19:377–85.10.1159/00034214123075771
142. Ferreira LC Regner A Miotto KD Moura Sd Ikuta N Vargas AE et al. Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj (2014) 28:1311–6.10.3109/02699052.2014.91681824830571
143. Kumar RG Boles JA Wagner AK. Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12 months postinjury. J Head Trauma Rehabil (2014).10.1097/HTR.000000000000006724901329
144. Rovlias A Kotsou S. The blood leukocyte count and its prognostic significance in severe head injury. Surg Neurol (2001) 55:190–6.10.1016/S0090-3019(01)00414-111358584
145. Pagowska-Klimek I Lewkowicz P Banasik M Krajewski W Tchórzewski H. Isolated head injury in children affects the neutrophil function and lymphocyte count. J Trauma (2007) 63:179–86.10.1097/TA.0b013e3180340dc917622887
146. Parment K Zetterberg A Ernerudh J Bakteman K Steinwall I Sjoberg F. Long-term immunosuppression in burned patients assessed by in vitro neutrophil oxidative burst (Phagoburst). Burns (2007) 33:865–71.10.1016/j.burns.2006.11.01117537580
147. Ishikawa K Tanaka H Takaoka M Ogura H Shiozaki T Hosotsubo H et al. Granulocyte colony-stimulating factor ameliorates life-threatening infections after combined therapy with barbiturates and mild hypothermia in patients with severe head injuries. J Trauma (1999) 46:999–1007.10.1097/00005373-199906000-0000410372615
148. Drifte G Dunn-Siegrist I Tissières P Pugin J. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome. Crit Care Med (2013) 41:820–32.10.1097/CCM.0b013e318274647d23348516
149. Wolach B Sazbon L Gavrieli R Ben-Tovim T Zagreba F Schlesinger M. Some aspects of the humoral and neutrophil functions in post-comatose nawareness patients. Brain Inj (1993) 7:401–10.10.3109/026990593090296838401482
150. Hergenroeder GW Moore AN McCoy JP Jr Samsel L Ward NH III Clifton GL et al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation (2010) 7:19.10.1186/1742-2094-7-1920222971
151. Gürkanlar D Lakadamyali H Ergun T Yilmaz C Yücel E Altinörs N. Predictive value of leucocytosis in head trauma. Turk Neurosurg (2009) 19:211–5.19621283
152. Vermeij FH Scholte op Reimer WJ de Man P van Oostenbrugge RJ Franke CL de Jong G et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands stroke survey. Cerebrovasc Dis (2009) 27:465–71.10.1159/00021009419329851
153. Harms H Prass K Meisel C Klehmet J Rogge W Drenckhahn C et al. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One (2008) 3:e2158.10.1371/journal.pone.000215818478129
154. Vogelgesang A Grunwald U Langner S Jack R Bröker BM Kessler C et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke (2008) 39:237–41.10.1161/STROKEAHA.107.49363518048864
155. Urra X Cervera A Obach V Climent N Planas AM Chamorro A. Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke (2009) 40:1262–8.10.1161/STROKEAHA.108.53208519164783
156. Klehmet J Harms H Richter M Prass K Volk HD Dirnagl U et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2009) 158:1184–93.10.1016/j.neuroscience.2008.07.04418722511
157. Folyovich A Biró E Orbán C Bajnok A Varga V Béres-Molnár AK et al. Relevance of novel inflammatory markers in stroke-induced immunosuppression. BMC Neurol (2014) 14:41.10.1186/1471-2377-14-4124597828
158. Lam NY Rainer TH Chiu RW Joynt GM Lo YM. Plasma mitochondrial DNA concentrations after trauma. Clin Chem (2004) 50:213–6.10.1373/clinchem.2003.025783
159. Yamanouchi S Kudo D Yamada M Miyagawa N Furukawa H Kushimoto S. Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status. J Crit Care (2013) 28:1027–31.10.1016/j.jcrc.2013.05.00623787023
160. Gu X Yao Y Wu G Lv T Luo L Song Y. The plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome. PLoS One (2013) 8:e72834.10.1371/journal.pone.007283423977360
161. Simmons JD Lee YL Mulekar S Kuck JL Brevard SB Gonzalez RP et al. Elevated levels of plasma mitochondrial DNa DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg (2013) 258:591–8.10.1097/SLA.0b013e3182a4ea4623979273
162. Krychtiuk KA Ruhittel S Hohensinner PJ Koller L Kaun C Lenz M et al. Mitochondrial DNA and toll-like receptor-9 are associated with mortality in critically ill patients. Crit Care Med (2015).10.1097/CCM.000000000000131126448617
163. Kilbaugh TJ Lvova M Karlsson M Zhang Z Leipzig J Wallace DC et al. Peripheral blood mitochondrial DNA as a biomarker of cerebral mitochondrial dysfunction following traumatic brain injury in a porcine model. PLoS One (2015) 10:e0130927.10.1371/journal.pone.013092726098565
164. Kenne E Erlandsson A Lindbom L Hillered L Clausen F. Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice. J Neuroinflammation (2012) 9:17.10.1186/1742-2094-9-1722269349
165. Lee J Costantini TW D’Mello R Eliceiri BP Coimbra R Bansal V. Altering leukocyte recruitment following traumatic brain injury with ghrelin therapy. J Trauma Acute Care Surg (2014) 77:709–15.10.1097/TA.000000000000044525494422
166. Corser-Jensen CE Goodell DJ Freund RK Serbedzija P Murphy RC Farias SE et al. Blocking leukotriene synthesis attenuates the pathophysiology of traumatic brain injury and associated cognitive deficits. Exp Neurol (2014) 256:7–16.10.1016/j.expneurol.2014.03.00824681156
167. Heard SO Fink MP Gamelli RL Solomkin JS Joshi M Trask AL et al. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med (1998) 26:748–54.10.1097/00003246-199804000-00027
168. Wong CH Jenne CN Lee WY Léger C Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science (2011) 334:101–5.10.1126/science.121030121921158
169. Gardner JC Noel JG Nikolaidis NM Karns R Aronow BJ Ogle CK et al. G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol (2014) 192:2405–17.10.4049/jimmunol.130275224470495
170. Kumagai T Takeyama N Yabuki T Harada M Miki Y Kanou H et al. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock (2010) 34:461–6.10.1097/SHK.0b013e3181e14ca020386499